OR WAIT null SECS
Houston-area mobile mammography program brings screening mammography and access to diagnostic services to women who have barriers to care.
Bringing mammography to women in underserved communities can go a long way toward improving their access to the healthcare services they need. Mobile programs frequently catch invasive cancers early, improving a woman’s prognosis.
And, that is exactly what MD Anderson Cancer Center’s VALET has done. According to a team of researchers, led by David Spak, M.D., assistant professor and breast imaging specialist, this mobile program has focused on bringing mammography services to women in low-income communities in the greater Houston area.
The team shared the program's five-year performance results in a recent study published in Academic Radiology.
“Mobile mammography is one of the best strategies to target women of lower socio-economic status to increase access,” the team said. “Mobile mammography is also associated with an increased participation rate as women are more likely to undergo mammography within three months if offered a mobile option and health education.”
From Oct. 1, 2012, to Sept. 30, 2017, Project Valuable Area Life-Saving Exams in Town (VALET) provided 9,327 screening mammograms to 7,391 women. Most women – 5,871 (79.4 percent) – only received one examination, but the remaining participants received up to six screenings. The majority of women (76 percent) were Hispanic, and other patients were black (10 percent), Asian (8 percent), and white (4 percent).
The program has a budget of $1.6 million-to-$2 million, and it concentrates on women who have a variety of barriers to care, including travel costs, insurance, appointment availability, and procedure costs.
Of all the studies, 1,686 were recalled for identified abnormalities, accounting for a 17.8-percent recall rate. A total of 101 exams were sent for biopsy, identifying 14 malignancies – 11 of which were invasive. The average tumor size was 2.3 cm, and the overall cancer detection rate was 1.5 cancers per 1,000 screenings. Fortunately, the team reported, the majority of the breast cancer identified demonstrated ER+, PR+ and HER2-receptor status, making them susceptible to hormonal therapy and placing a woman at lower risk for local or regional recurrence.
“These cases of invasive disease highlight the importance of mammographic screening for a patient population that may not have access to screening,” Spak wrote. “If these small, invasive cancers are allowed to progress, then the cost of treatment at a later stage can be more expensive.”
VALET offers several benefits, Spak’s team said. Not only does it potentially provide earlier detection for women, but multi-lingual patient navigators and technologists also improve efficiency, reduce patient history-related errors, and improve the experience for the patient overall. In addition, program staff can also connect patients with navigation services and can send patients reminders to avoid missing appointments.
Alongside mammography services, VALET coordinators are also exploring ways to incorporate digital breast tomosynthesis and whole breast ultrasound into the mobile program. Ultimately, the team said, they hope their program can serve as a model for other initiatives nationwide.
“These findings support the need for the development of similar programs in other areas in the United States with a mission to care for the underserved community,” they wrote. “Additionally, further investigation into mobile mammography programs would be helpful to identify patient factors, logistics, and technology, including digital breast tomosynthesis, that might prove beneficial.”